GOLDMAN SACHS GROUP INC - LARIMAR THERAPEUTICS INC ownership

LARIMAR THERAPEUTICS INC's ticker is LRMR and the CUSIP is 517125100. A total of 67 filers reported holding LARIMAR THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of LARIMAR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$535,624
+26.7%
135,601
+0.4%
0.00%
Q2 2023$422,854
-47.2%
135,097
-23.6%
0.00%
Q1 2023$801,271
+72.2%
176,881
+57.0%
0.00%
Q4 2022$465,393
+138.7%
112,686
+84.9%
0.00%
Q3 2022$195,000
+29.1%
60,930
+366.8%
0.00%
Q3 2021$151,000
+7.1%
13,053
-8.8%
0.00%
Q2 2021$141,00014,3140.00%
Other shareholders
LARIMAR THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
CHI Advisors LLC 3,473,366$14,345,0013.82%
Opaleye Management Inc. 1,560,000$6,442,8002.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 16,941,357$69,967,8041.45%
GREAT POINT PARTNERS LLC 1,273,635$5,260,1131.03%
DAFNA Capital Management LLC 473,136$1,954,0520.55%
COMMODORE CAPITAL LP 750,000$3,0980.47%
Cheyne Capital Management (UK) LLP 63,680$262,9980.46%
Atlas Venture Advisors, Inc. 292,184$1,206,7200.42%
Perceptive Advisors 2,860,000$11,811,8000.33%
MANGROVE PARTNERS IM, LLC 1,292,812$5,339,3140.30%
View complete list of LARIMAR THERAPEUTICS INC shareholders